The Effect Of Transcranial Direct Current Stimulation In Panic Disorder
PDStim
The Effect Of Prefrontal Transcranial Direct Current Stimulation On Clinical Severity, Attentional Bias and Interoceptive Accuracy In Panic Disorder
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of the present study is to investigate the effect of prefrontal transcranial Direct Current Stimulation (tDCS) on clinical severity, attentional bias and interoceptive accuracy in panic disorder (PD). The participants will be assigned to active and sham groups (1:1) and will receive 10 sessions of tDCS. The study will also examine if the effects may last for a month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 8, 2019
CompletedFirst Posted
Study publicly available on registry
November 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedOctober 4, 2022
October 1, 2022
2 years
November 8, 2019
October 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Changes in Panic Disorder Severity Scale (PDSS) scores
The PDSS consists of seven items, each rated on a 5-point scale, which ranges from 0 to 4. The items assess panic frequency, resulting distress, panic-focused anticipatory anxiety, phobic avoidance of situations and of physical sensations, impairment in occupational and social functioning. The overall assessment is made by a total score, which is calculated by summing the scores for all seven items. Minimum score is 0 and maximum score is 28. Higher scores indicate high levels of panic symptomatology. Reduction in score from baseline indicates clinical improvement of panic symptoms.
Up to one month
Changes in Hamilton Anxiety Rating Scale (HAM-A) scores
The Hamilton Anxiety Rating Scale (HAM-A) is a multiple item questionnaire used to provide an indication of anxiety severity. Higher scores indicate high levels of symptomatology. Minimum score is 0 and maximum score is 56. Reduction in score from baseline indicates clinical symptom improvement.
Up to one month
Changes in Clinical Global Impression-Severity (CGI-S) scores
Higher scores indicate the presence of high symptom severity. Decrease in scores from baseline reflects clinical symptom improvement. Minimum score is 1 and maximum score is 7. Patients will be classified as responders with a CGI-S = 1 or 2; and partial responders CGI-S = 3.
Up to one month
Changes in performance on an attentional dot-probe task
Computerized "dot-probe " attentional task will be used. Pairs of emotional faces (neutral/angry or neutral/happy) are randomly presented on a screen. Then, a probe is presented. Subjects are asked to indicate which side the probe approved and need to press the dot after the probe. Total time spent on Region of Interest (angry/neutral face) is measured. Attentional bias towards threat score is the subtraction of median reaction times (milliseconds) in congruent angry versus neutral trials from incongruent angry versus neutral trials. Minimum score is -1000 and maximum score is 1000. Positive scores indicate the presence of attentional vigilance towards threat whereas negative scores indicate an attentional avoidance towards threat.
Up to one month
Secondary Outcomes (8)
Changes in Hamilton Depression Rating Scale (HAM-D) scores
Up to one month
Changes in Beck Depression Inventory (BDI) scores
Up to one month
Changes in Sheehan Disability Scale (SDS) Work/School scores
Up to one month
Changes in Sheehan Disability Scale (SDS) Social Life scores
Up to one month
Changes in Sheehan Disability Scale (SDS) Family Life/Home Responsibilities scores
Up to one month
- +3 more secondary outcomes
Study Arms (2)
Active Group
ACTIVE COMPARATORLeft anodal/right anodal transcranial direct current stimulation over the dorsolateral prefrontal cortex
Sham Group
SHAM COMPARATORSham transcranial direct current stimulation over the dorsolateral prefrontal cortex
Interventions
Participants will receive a total of 10 stimulation sessions. During each session, 2 milliAmpers of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (left anodal/right anodal).
Eligibility Criteria
You may qualify if:
- Patients with a primary diagnosis of Panic Disorder, as confirmed by the Structured Clinical Interview for the DSM-5 (SCID-5);
- Patients currently on medication must be at the same stable dose(s) for one month prior to enrollment and be willing to continue at the same dose(s) through the duration of the study;
- Right-hand dominancy assessed by Edinburgh Handedness Inventory;
- Willingness and ability to comply with the requirements of the study protocol;
- Naïve to tDCS.
- or more years of education
You may not qualify if:
- Illiteracy, deficient language or refusal to participate or being not able to follow instructions or complete study tasks;
- Less than 5 years of education
- Individuals with any current or lifetime diagnosis of other Axis I disorders, as confirmed by the Structured Clinical Interview for the DSM-5 (SCID-5);
- History of substance or psychoactive compound use,with the exception of nicotine consumption;
- The presence of mental retardation diagnosis (previously identified)
- Individuals with a clinically defined neurological disorder, with an increased risk of seizure for any reason, with a history of treatment with rTMS, deep brain stimulation for any disorder will be excluded;
- Any personal or family history (1st degree relatives) of seizures other than febrile childhood seizures
- Personal history of head trauma that resulted in loss of consciousness for \> 5 minutes and retrograde amnesia for \> 30 minutes;
- Significant hearing loss or visual impairment;
- Diagnosis of any serious or uncontrolled medical condition such as chronic obstructive pulmonary disease, congestive heart failure or renal failure;
- Skin diseases that could potentially cause irritations under electrodes;
- Patients missing two consecutive protocol sessions;
- Patients with cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute, unstable cardiac disease, with intracranial implants (e.g. aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department Of Psychiatry, Istanbul University
Istanbul, 34060, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raşit Tükel, Professor
Istanbul University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
November 8, 2019
First Posted
November 13, 2019
Study Start
November 1, 2019
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
October 4, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share